Skip to main content
. 2020 Aug 10;36(2):254–263. doi: 10.1007/s12250-020-00274-7

Table 3.

Concentration–responses of aristolactam derivatives on the inhibition of Tat-induced HIV-1 transcription.

Compound IC50 (μmol/L)a
1 1.11 ± 0.02
2 2.85 ± 0.17
3 2.58 ± 0.05
4 3.40 ± 0.02
5 1.36 ± 0.01
6 2.47 ± 0.26
7 1.78 ± 0.15
8 2.25 ± 0.24
9 3.38 ± 0.05
Seliciclib 2.25 ± 0.14

aThe compounds were assessed in bl-DTR cells using a concentration–response test.